Evaluation and management of psoriasis: an internist's guide
- PMID: 19932332
- DOI: 10.1016/j.mcna.2009.08.003
Evaluation and management of psoriasis: an internist's guide
Abstract
Psoriasis is a debilitating chronic skin condition that afflicts millions of patients worldwide. Patients experiencing psoriasis report a magnitude of impaired quality of life that is often similar to that of patients who have heart failure and cancer. Many patients who have psoriasis are even themselves at risk for developing heart disease, metabolic syndrome, certain cancers, and psychiatric illness. Therefore, primary care physicians must appreciate the current psoriatic disease model and share a basic understanding of psoriasis management. This article reviews the epidemiology, clinical features, pathogenesis, comorbidities, and treatment of psoriasis, with special emphasis placed on the new class of medications, biologics, which are revolutionizing the management of the disease.
Similar articles
-
Psoriasis and psoriatic arthritis: clinical features and disease mechanisms.Clin Dermatol. 2006 Sep-Oct;24(5):438-47. doi: 10.1016/j.clindermatol.2006.07.006. Clin Dermatol. 2006. PMID: 16966023 Review.
-
Childhood psoriasis.Clin Dermatol. 2007 Nov-Dec;25(6):555-62. doi: 10.1016/j.clindermatol.2007.08.009. Clin Dermatol. 2007. PMID: 18021892 Review.
-
Psoriasis and psoriatic arthritis overview.Am J Manag Care. 2016 Jun;22(8 Suppl):s216-24. Am J Manag Care. 2016. PMID: 27356193 Review.
-
Phototherapy of psoriasis in the era of biologics: still in.Acta Dermatovenerol Croat. 2011;19(3):195-205. Acta Dermatovenerol Croat. 2011. PMID: 21933648 Review.
-
Biologics for the primary care physician: Review and treatment of psoriasis.Dis Mon. 2019 Mar;65(3):51-90. doi: 10.1016/j.disamonth.2018.06.001. Epub 2018 Jul 20. Dis Mon. 2019. PMID: 30037762 Review.
Cited by
-
Effectiveness comparisons of traditional Chinese medicine for psoriasis: A Bayesian network meta-analysis.Medicine (Baltimore). 2019 Sep;98(36):e17055. doi: 10.1097/MD.0000000000017055. Medicine (Baltimore). 2019. PMID: 31490403 Free PMC article.
-
An Analysis of IL-10, IL-17A, IL-17RA, IL-23A and IL-23R Expression and Their Correlation with Clinical Course in Patients with Psoriasis.J Clin Med. 2021 Dec 13;10(24):5834. doi: 10.3390/jcm10245834. J Clin Med. 2021. PMID: 34945130 Free PMC article.
-
Burden of Moderate-to-Severe Plaque Psoriasis and New Therapeutic Approaches (Secukinumab): An Italian Perspective.Dermatol Ther (Heidelb). 2016 Jun;6(2):151-67. doi: 10.1007/s13555-016-0114-9. Epub 2016 Apr 15. Dermatol Ther (Heidelb). 2016. PMID: 27083437 Free PMC article. Review.
-
Psoriasis in Childbearing Age: A Real-Life, Retrospective, Single-Center Study on Anti-IL17 and IL-23 Agents.J Clin Med. 2024 Oct 25;13(21):6401. doi: 10.3390/jcm13216401. J Clin Med. 2024. PMID: 39518540 Free PMC article.
-
Deterioration of Health-Related Quality of Life After Withdrawal of Risankizumab Treatment in Patients with Moderate-to-Severe Plaque Psoriasis: A Machine Learning Predictive Model.Dermatol Ther (Heidelb). 2021 Aug;11(4):1291-1304. doi: 10.1007/s13555-021-00550-8. Epub 2021 May 21. Dermatol Ther (Heidelb). 2021. PMID: 34019229 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical